CDER Request for Information Docket FDA-2026-E-4491
Summary
The FDA Center for Drug Evaluation and Research (CDER) issued a Request for Information under Docket FDA-2026-E-4491, soliciting public comments on matters within CDER's regulatory purview. The document was posted on regulations.gov with an attached PDF containing the full RFI text. No other documents were available for viewing or download at time of access.
About this source
Every FDA document on regulations.gov, the federal rulemaking portal. This is where the agency posts variances, advisory committee meeting notices, draft guidance for comment, citizen petition responses, and procedural rules that do not get a separate Federal Register slot. Around 240 a month. FDA's heavy regulations.gov use means tracking only the Federal Register misses a meaningful chunk of what the agency does day-to-day. Watch this if you manufacture devices, submit IND or NDA applications, run a lab, or advise sponsors on FDA process. GovPing publishes each posting with the docket, document type, division (CDER, CDRH, CFSAN), and comment window where one applies.
What changed
CDER has initiated a Request for Information process for Docket FDA-2026-E-4491. The source materials indicate only that CDER authored the RFI and posted it to regulations.gov; the specific subject matter of the inquiry is not visible in the available source content. Interested parties should monitor regulations.gov for the full RFI document and any associated Federal Register notice providing context on the specific regulatory topic under consideration.
Affected parties—including pharmaceutical manufacturers, drug manufacturers, and clinical investigators—should review the complete RFI once published to determine whether their operations or products fall within the scope of CDER's inquiry and assess whether submission of comments is warranted.
Archived snapshot
Apr 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Content
There are no documents available to view or download
Attachments 1
Request for Information
More Information
- Author(s) CDER
Download
Mentioned entities
Related changes
Get daily alerts for Regs.gov: Food and Drug Administration
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.